Browse > Article
http://dx.doi.org/10.7841/ksbbj.2011.26.5.393

Evaluation of Nattokinase for Antithrombotic Effect and Pharmacological Efficacy by a Biological Test and Clinical Trial  

Kim, Jae-Bum (KPX Bio-Tech Co., LTD.)
Yoo, Chul-Bae (KPX Bio-Tech Co., LTD.)
Shin, Hyun-Man (KPX Bio-Tech Co., LTD.)
Jung, Joon-Ki (Division of Biotechnology R&D, KRIBB)
Jang, Hyung-Wook (KPX Bio-Tech Co., LTD.)
Publication Information
KSBB Journal / v.26, no.5, 2011 , pp. 393-399 More about this Journal
Abstract
Bacillus subtilis natto producing high level of a fibrinolytic enzyme was selected and Ultra Nattokinase$^{(R)}$ was manufactured by fermentation and purification. It was performed the evaluation of the antithrombotic effect of Ultra Nattokinase$^{(R)}$ (20,000 FU/g) with rat blood plasma. The maximum aggregation (inhibition ratio) was 71% (0%), 69% (2.8%), 62% (12.7%), 16% (77.5%) and 9% (87.3%), respectively, in the order of 0, 5, 10, 50 and 100 mg/mL of Ultra Nattokinase$^{(R)}$ solutions. Ultra Nattokinase$^{(R)}$ had antithrombotic effect, which was associated with the suppression of collagen-induced platelet aggregation. Ultra Nattokinase$^{(R)}$ in the topic of the FDP (fibrinogen degradation products) in blood coagulation tests showed a significant increasing trend. And based on the daily record of meal 39 people of ITT (what ?) group consisted with 19 people of NP (what ?) group and 20 people of PN (what ?) group except four people, two people who took vitamin K affecting the experiment and two people who took alcohol, finding to be taken Ultra Nattokinase$^{(R)}$ showed an increase in the FDP value after four weeks. In addition, FDP value of 41 people of ITT group except two people having metabolic syndrome was increased by Ultra Nattokinase$^{(R)}$.
Keywords
Bacillus subtilis natto; Ultra Nattokinase$^{(R)}$; Antithrombotic effect; Pharmacological efficacy; FDP;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Fujita, M., K. Nomura, K. Hong, Y. Ito, A. Asada, and S. Nishimuro (1993) Purification and characterization of a strong fibrinolytic enzyme (nattokinase) in the vegetable cheese natto, a popular soybean fermented food in Japan. Biochem. Biophys. Res. Commun. 197: 1340-1347.   DOI   ScienceOn
2 Al Dieri R., S. Alban, S. Béguin, and H. C. Hemker (2004) Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time. J. Thromb. Haemost. 2: 1395-1401.   DOI   ScienceOn
3 Chang, Y. Y., J. S. Liu, S. L. Lai, H. S. Wu, and M. Y. Lan (2008) Cerebellar hemorrhage provoked by combined use of nattokinase and aspirin in a patient with cerebral microbleeds. Intern. Med. 47: 467-469.   DOI   ScienceOn
4 Omura, K., M. Hitosugi, X. Zhu, M. Ikeda, H. Maeda, and S. Tokudome (2005) A newly derived protein from Bacillus subtilis natto with both antithrombotic and fibrinolytic effects. J. Pharmacol. Sci. 99: 247-251.   DOI   ScienceOn
5 Omura, K., M. Hitosugi, K. Kaketani, X. Zhu, H. Maeda, and S. Tokudome (2004) Fibrinolytic and anti-thrombotic effect of NKCP, the protein layer from Bacillus subtilis natto. Biofactors 22: 185-187.   DOI
6 Maat, M. P., A. C. de Bart, B. C. Hennis, P. Meijer, A. C. Havelaar, P. G. Mulder, and C. Kluft (1996) Interindividual and intraindividual variability in plasma fibrinogen, TPA antigen, PAI activity, and CRP in healthy, young volunteers and patients with angina pectoris. Arterioscler. Thromb. Vasc. Biol. 16: 1156-1162.   DOI   ScienceOn
7 Yamamoto, K., K. Takeshita, T. Kojima, J. Takamatsu, and H. Saito (2005) Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc. Res. 66: 276-285.   DOI   ScienceOn
8 Borawski, J. and M. Myśliwiec (2001) Plasma fibrinogen level is an important determinant of prolonged euglobulin clot lysis time in hemodialysis patients. Clin. Appl. Thromb. Hemost. 7: 296-299.   DOI   ScienceOn
9 Kowalski, E., M. Kopec, and Niewiarowski (1959) An evaluation of the euglobulin method for the determination of fibrinolysis. J. Clin. Pathol. 12: 215-218.   DOI
10 Sumi, H., H. Hamada, K. Nakanishi, and H. Hiratani (1990) Enhancement of the fibrinolytic activity in plasma by oral administration of nattokinase. Acta Haematologica 84: 139-143.   DOI   ScienceOn
11 Sasaki, K., S. Moriyama, Y. Tanaka, H. Sumi, N. Toki, and K. C. Robbins (1985) The transport of 125I-labeled human high molecular weight urokinase across the intestinal tract in a dog model with stimulation of synthesis and/or release of plasminogen activators. Blood 66: 69-75.
12 Hirofumi O., T. Iwakoshi, M. Niwa, Y. Kida, T. Tanaka, R. Kitamura, S. Maezawa, and T. Kobayashi (1996) Coagulation and fibrinolysis study after local thrombolysis of a cerebral artery with urokinase. Neurol. Med. Chir. (Tokyo) 36: 300-304.   DOI   ScienceOn
13 Yoo, C. K., W. S. Seo, C. S. Lee, and S. M. Kang (1998) Purification and characterization of fibrinolytic enzyme excreted by Bacillus subtilis K-54 isolated from Chung Guk Jang. Korean J. Appl. Microbiol. Biotechnol. 26: 507-514.
14 Astrup, T. and S. Mullertz (1952) The fibrin plate method for estimating fibrinolytic activity. Archs. Biochem. Biophys. 40: 346-347.   DOI   ScienceOn
15 Anson, M. L. (1939) The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin. J. Gen. Physiol. 22: 78-89.
16 Kimura, S., M. T. Chiang, and H. Fujimoto (1990) Effects of eicosapentanoic acid an soybean protein on plasma cholesterol, blood pressure and platelet aggregation in stroke prone spontaneously hypertensive rats. Monogr. Atheroscler. 16: 26-35.